The Trump administration issued regulations Friday that could lower the prices Americans pay for many prescription drugs. In announcing the new policy President Donald Trump again claimed he had won the presidential election. (Nov. 20)
But in a time of political uncertainty, it's hard to say whether the rules will withstand expected legal challenges from the pharmaceutical industry or whether the incoming Biden administration will accept, amend or try to roll them back entirely.
"The drug companies don't like me too much. But we had to do it," President Donald Trump said in announcing the new policy at the White House. "I just hope they keep it. I hope they have the courage to keep it," he added, noting pressure from drug company lobbyists.
"Big Pharma ran millions of dollars of negative advertisements against me during the campaign, which I won, by the way," Trump told reporters.
The two finalized rules, long in the making, would:
— tie what Medicare pays for medications administered in a doctor's office to the lowest price paid among a group of other economically advanced countries. That's called the "most favored nations" approach. It is adamantly opposed by critics aligned with the pharmaceutical industry, who liken it to socialism. The administration estimates it could save $28 billion over seven years for Medicare recipients through lower copays. It would take effect Jan. 1.
— require drugmakers, for brand name pharmacy medications, to give Medicare enrollees rebates that now go to insurers and middlemen called pharmacy benefit managers. Insurers that deliver Medicare's "Part D" prescription benefit say that would raise premiums. The nonpartisan Congressional Budget Office estimates it would increase taxpayer costs by $177 billion over 10 years. The Trump administration disputes that and says its rule could potentially result in 30% savings for patients. It would take effect Jan. 1, 2022.
The industry is considering "all options to stop this reckless attack on the companies working around the clock to beat COVID-19," the Pharmaceutical Research and Manufacturers of America said in a statement.
Trump came into office accusing pharmaceutical companies of "getting away with murder" and complaining that other countries whose governments set drug prices were taking advantage of Americans.
Subscribe for more Breaking News: [ Ссылка ]
Website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Google+: [ Ссылка ]
Instagram: [ Ссылка ]
You can license this story through AP Archive: [ Ссылка ]
